Pharmacoeconomic Analysis of Medicines Used for Bronchial Asthma in Children in Kazakhstan
References
- Website: World Health Organisation. Asthma. 2024.
https://www.who.int/news-room/fact-sheets/detail/asthma - Website: World Health Organisation. Asthma. 2020.
https://www.who.int/news-room/facts-in-pictures/detail/asthma - Nugmanova D, Sokolova L, Feshchenko Y, Iashyna L, Gyrina O, Malynovska K, et al. The prevalence, burden and risk factors associated with bronchial asthma in commonwealth of independent states countries (Ukraine, Kazakhstan and Azerbaijan): Results of the CORE study. BMC Pulm Med. 2018;18(1):110. doi: 10.1186/s12890-018-0676-7
- Comité Nacional de Neumonología. Guideline on diagnosis and treatment: Bronchial asthma in children ≥ 6 years old. Update 2021. Arch Argent Pediatr. 2021;119(4):S123–S158. doi: 10.5546/aap.2021.S123
- Tiotiu AI, Novakova P, Nedeva D, Chong-Neto HJ, Novakova S, Steiropoulos P, et al. Impact of air pollution on asthma outcomes. Int J Environ Res Public Health. 2020;17(17):6212. doi: 10.3390/ijerph17176212
- Zanobetti A, Ryan PH, Coull B, Brokamp C, Datta S, Blossom J, et al. Children’s respiratory and environmental workgroup (CREW) consortium. Childhood asthma incidence, early and persistent wheeze, and neighborhood socioeconomic factors in the ECHO/CREW consortium. JAMA Pediatr. 2022;176(8):759–767. doi: 10.1001/jamapediatrics.2022.1446
- D’Amato G, Chong-Neto HJ, Monge Ortega OP, Vitale C, Ansotegui I, Rosario N, et al. The effects of climate change on respiratory allergy and asthma induced by pollen and mold allergens. Allergy. 2020;75(9):2219–2228. doi: 10.1111/all.14476
- Keet CA, Matsui EC, McCormack MC, Peng RD. Urban residence, neighborhood poverty, race/ethnicity, and asthma morbidity among children on Medicaid. J Allergy Clin Immunol. 2017;140(3):822–827. doi: 10.1016/j.jaci.2017.01.036
- Beck AF, Moncrief T, Huang B, Simmons JM, Sauers H, Chen C, et al. Inequalities in neighborhood child asthma admission rates and underlying community characteristics in one US county. J Pediatr. 2013;163(2):574–580. doi: 10.1016/j.jpeds.2013.01.064
- Serikbayeva EA, Zhakipbekov KS, Umurzakhova GZh, Datkhayev UM, Kauypova FE, Dyusembinova GA. Methods of assessing the possibility of forming a branch regional clusters in RK. Syst Rev Pharm. 2020;11(6):425–434. doi: 10.31838/srp.2020.6.68
- Issatayeva N, Datkhayev U, Zhakipbekov K, Serikbayeva E, Umirzakhova G. Public-private partnership in the healthcare and pharmaceutical sectors of Kazakhstan: Problems and solutions. J Adv Res Law Econ. 2020;11(3):876–884. doi: 10.14505/jarle.v11.3(49).22
- Ashirov MZ, Datkhayev UM, Myrzakozha DA, Sato H, Zhakipbekov KS, Rakhymbayev NA, et al. Study of cold-pressed tobacco seed oil properties by gas chromatography method. Sci World J. 2020;2020(1):8852724. doi: 10.1155/2020/8852724
- Tleubayeva MI, Abdullabekova RM, Datkhayev UМ, Ishmuratova MY, Alimzhanova MB, Kozhanova KK, et al. Investigation of CO2 extract of portulaca oleracea for antioxidant activity from raw material cultivated in Kazakhstan. Int J Biomater. 2022;2022:6478977. doi: 10.1155/2022/6478977
- Umurzakhova G, Sultanbekov A, Issatayeva N, Zhakipbekov K, Shopabaeva A, Shertaeva C, et al. Communication skills as one of the main competences of pharmacists. Ann Trop Med Public Health. 2018;11(3):62–69. doi: 10.4103/ATMPH.ATMPH_194_17
- Datkhayev U, Shopabaeva A, Zhakipbekov K, Shertaeva C, Umurzakhova G, Sultanbekov A, et al. Determination of seasonal demand for pharmaceutical staff. Int J Pharm Sci Rev Res. 2016;36(2):105–111.
- Smirnova OV. Pharmacoeconomic aspects of bronchial asthma. Bull Vitebsk State Med Univ. 2004;3(3):40–46.
- Wu P, Xu B, Shen A, He Z, Zhang CJ, Ming WK, et al. The economic burden of medical treatment of children with asthma in China. BMC Pediatr. 2020;20(1):386. doi: 10.1186/s12887-020-02268-6
- Finkelstein EA, Lau E, Doble B, Ong B, Koh MS. Economic burden of asthma in Singapore. BMJ Open Respir Res. 2021;8(1):e000654. doi: 10.1136/bmjresp-2020-000654
- Nurmagambetov T, Kuwahara R, Garbe P. The economic burden of asthma in the United States, 2008–2013. Ann Am Thorac Soc. 2018;15(3):348–356. doi: 10.1513/annalsats.201703-259oc
- Perry R, Braileanu G, Palmer T, Stevens P. The economic burden of pediatric asthma in the United States: Literature review of current evidence. Pharmacoeconomics. 2019;37(2):155–167. doi: 10.1513/AnnalsATS.201703-259OC
- Chen W, Safari A, FitzGerald JM, Sin DD, Tavakoli H, Sadatsafavi M. Economic burden of multimorbidity in patients with severe asthma: A 20-year population-based study. Thorax. 2019;74(12):1113–1119. doi: 10.1136/thoraxjnl-2019-213223
- Rank M, Landman N, Harootunian G, Winscott M, Jain N, Frey K, et al. Variability in asthma quality and costs in children with different Medicaid insurance plans in Maricopa County. J Asthma. 2019;56(2):152–159. doi: 10.1080/02770903.2018.1432644
- Chastek B, Korrer S, Nagar SP, Albers F, Yancey S, Ortega H, et al. Economic burden of illness among patients with severe asthma in a managed care setting. J Manag Care Spec Pharm. 2016;22(7):848–861. doi: 10.18553/jmcp.2016.22.7.848
- Tabyshova A, Emilov B, Postma MJ, Chavannes NH, Sooronbaev T, van Boven JFM. Prevalence and economic burden of respiratory diseases in Central Asia and Russia: A systematic review. Int J Environ Res Public Health. 2020;17(20):7483. doi: 10.3390/ijerph17207483
- Vinnikov D, Raushanova A, Mukatova I, Nurpeissov T, Кushekbayeva A, Toxarina A, et al. Asthma control in Kazakhstan: Need for urgent action. BMC Pulm Med. 2023;23:7. doi: 10.1186/s12890-022-02287-2
- Website: WMA Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects. World Medical Association; 1964.
https://web.archive.org/web/20110830192613/ http://www.wma.net/en/30publications/10policies/b3/index.html - Geller LN, Petrov VP, Radnaev GG. Pharmacoeconomical a substantiation of efficiency of use of medical products in the treatment of a bronchial asthma in children. Sib Med J. 2006;9:68–70.
- Xu H, Tong L, Gao P, Hu Y, Wang H, Chen Z, et al. Combination of ipratropium bromide and salbutamol in children and adolescents with asthma: A meta-analysis. PLoS One. 2021;16(2):e0237620. doi: 10.1371/journal.pone.0237620
- Wongwaree S, Daengsuwan T. Comparison efficacy of randomized nebulized magnesium sulfate and ipratropium bromide/fenoterol in children with moderate to severe asthma exacerbation. Asian Pac J Allergy Immunol. 2022;40(1):31–38. doi: 10.12932/AP-190717-0118
- Pitrez PM, Nanthapisal S, Castro AP, Teli C, Abhijith PG. Managing moderate-to-severe paediatric asthma: A scoping review of the efficacy and safety of fluticasone propionate/salmeterol. BMJ Open Respir Res. 2023;10(1):e001706. doi: 10.1136/bmjresp-2023-001706
- Chipps BE, Albers FC, Reilly L, Johnsson E, Cappelletti C, Papi A. Efficacy and safety of as-needed albuterol/budesonide versus albuterol in adults and children aged ≥4 years with moderate-to-severe asthma: Rationale and design of the randomised, double-blind, active-controlled MANDALA study. BMJ Open Respir Res. 2021;8(1):e001077. doi: 10.1136/bmjresp-2021-001077
- Rege S, Kavati A, Ortiz B, Mosnaim G, Cabana MD, Murphy K, et al. Documentation of asthma control and severity in pediatrics: Analysis of national office-based visits. J Asthma. 2020;57(2):205–216. doi: 10.1080/02770903.2018.1554069
- Pugliese FR, Guglielmelli E, Angelini D, Cicchini C, Castaldo E, Di Girolamo F, et al. Pharmacoeconomic management of patient with severe asthma in the Emergency Department: Retrospective multicentric and cost of illness study. Eur Rev Med Pharm Sci. 2020;24(22):11729–11739. doi: 10.26355/eurrev_202011_23824
- Menzella F, Galeone C, Ghidoni G, Ruggiero P, D’Amato M, Fontana M, et al. The pharmacoeconomics of the state-of-the-art drug treatments for asthma: A systematic review. Multidiscip Respir Med. 2021;16(1):787. doi: 10.4081/mrm.2021.787
- Zyryanov SK, Dyakov IN, Aisanov ZR. Pharmacoeconomics analysis of using a fixed combination of budesonide/formoterol in patients with asthma in the health care system of the Russian Federation. Ther Arch. 2022;94(7):850–858. doi: 10.26442/00403660.2022.07.201715
- Lane S, Molina J, Plusa T. An international observational prospective study to determine the cost of asthma exacerbations (COAX). Respir Med. 2006;100(3):434–450. doi: 10.1016/j.rmed.2005.06.012
- Halmai LA, Neilson AR, Kilonzo M. Economic evaluation of interventions for the treatment of asthma in children: A systematic review. Pediatr Allergy Immunol. 2020;31(2):150–157. doi: 10.1111/pai.13129
DOI: https://doi.org/10.34763/jmotherandchild.20252901.d-24-00046 | Journal eISSN: 2719-535X | Journal ISSN: 2719-6488
Language: English
Page range: 20 - 29
Submitted on: Nov 4, 2024
Accepted on: Feb 13, 2025
Published on: May 24, 2025
Published by: Institute of Mother and Child
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Related subjects:
© 2025 Elmira Serikbayeva, Nizom Suyunov, Baurzhan Makhatov, Ainash Atimtaikyzy, Aigul Ibragimova, Maksuda Abdullaeva, published by Institute of Mother and Child
This work is licensed under the Creative Commons Attribution 4.0 License.